title: Let cost effectiveness models be open to scrutiny.
authors.forename: Chris
authors.initials: C
authors.lastname: Poole
authors.forename: Samir
authors.initials: S
authors.lastname: Agrawal
authors.forename: Craig J
authors.initials: CJ
authors.lastname: Currie
mesh_terms: D003362:Cost-Benefit Analysis; D013222:State Medicine / Q000191:economics*; D013673:Technology Assessment, Biomedical / Q000191:economics*; D006113:United Kingdom